Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis

References

• Raue F, Frank-Raue K. Thyroid cancer: risk-stratified management and individualized therapy. Clin Cancer Res off J Am Assoc Cancer Res. 2016 Oct 15;22(20):5012–5021. PubMed PMID: 27742787; eng.
   PubMed Web of Science ®Google Scholar
• Lim H, Devesa SS, Sosa JA, et al. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. Jama. 2017 Apr 4;317(13):1338–1348. PubMed PMID: 28362912; eng.
   PubMed Web of Science ®Google Scholar
• Miccoli P, Bakkar S. Surgical management of papillary thyroid carcinoma: an overview. Updates Surg. 2017 Jun;69(2):145–150. PubMed PMID: 28405952; eng.
   PubMed Web of Science ®Google Scholar
• Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol). 2010 Aug;22(6):395–404. PubMed PMID: 20627675; eng.
   PubMed Web of Science ®Google Scholar
• Khan U, Al Afif A, Aldaihani A, et al. Patient and tumor factors contributing to distant metastasis in well-differentiated thyroid cancer: a retrospective cohort study. J Otolaryngol. 2020 Nov 16;49(1):78. PubMed PMID: 33198797; PubMed Central PMCID: PMCPMC7667857. eng.
   Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017 Oct 12;36(41):5661–5667. PubMed PMID: 28604750; PubMed Central PMCID: PMCPMC6450570. eng.
   PubMed Web of Science ®Google Scholar
• Mahmoudian-Sani MR, Jalali A, Jamshidi M, et al. Long non-coding RNAs in thyroid cancer: implications for pathogenesis, diagnosis, and therapy. Oncol Res Treat. 2019;42(3):136–142. PubMed PMID: 30799425; eng.
   PubMed Web of Science ®Google Scholar
• Javed Z, Ahmed Shah F, Rajabi S, et al. LncRNAs as potential therapeutic targets in thyroid cancer. Asian Pac J Cancer Prev. 2020 Feb 1;21(2):281–287. PubMed PMID: 32102500; PubMed Central PMCID: PMCPMC7332117. eng.
   PubMedGoogle Scholar
• Shi F, Liu Y, Li M, et al. Analysis of lncRNA and mRNA transcriptomes expression in thyroid cancer tissues among patients with exposure of medical occupational radiation. Dose-resp Publ Int Horm Soc. 2019 Jul-Sep;17(3):1559325819864223. PubMed PMID: 31384241; PubMed Central PMCID: PMCPMC6661800. eng.
   Web of Science ®Google Scholar
• Xiang C, Zhang ML, Zhao QZ, et al. LncRNA-SLC6A9-5:2: a potent sensitizer in 131I-resistant papillary thyroid carcinoma with PARP-1 induction. Oncotarget. 2017 Apr 4;8(14):22954–22967. PubMed PMID: 28086241; PubMed Central PMCID: PMCPMC5410277. eng.
   PubMedGoogle Scholar
• Ding S, Qu W, Jiao Y, et al. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway. Cancer Biomarkers. 2018;22(2):217–226. PubMed PMID: 29630517; eng.
   PubMed Web of Science ®Google Scholar
• Qi X, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015 Oct;52(10):710–718. PubMed PMID: 26358722; eng.
   PubMed Web of Science ®Google Scholar
• Wu DM, Wang S, Wen X, et al. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Cell Death Dis. 2018 Sep 20;9(10):947. PubMed PMID: 30237435; PubMed Central PMCID: PMCPMC6148237. eng.
   PubMedGoogle Scholar
• Chen N, Yin D, Lun B, et al. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis. Biosci Rep. 2019 Jan 31;39(1). DOI:https://doi.org/10.1042/bsr20181440. PubMed PMID: 30429236; PubMed Central PMCID: PMCPMC6328895. eng.
   Google Scholar
• Lei H, Gao Y, Xu X. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Acta Biochim Biophys Sin (Shanghai). 2017 Jul 1;49(7):588–597. PubMed PMID: 28645161; eng.
   PubMed Web of Science ®Google Scholar
• Xu F, Li H, Hu C. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer. Biosci Rep. 2019 Jul 31;39(7). DOI:https://doi.org/10.1042/bsr20180551. PubMed PMID: 31127025; PubMed Central PMCID: PMCPMC6614576. eng.
   Google Scholar
• Wang Q, Wu J, Huang H, et al. lncRNA LIFR-AS1 suppresses invasion and metastasis of non-small cell lung cancer via the miR-942-5p/ZNF471 axis. Cancer Cell Int. 2020;20:180. PubMed PMID: 32489316; PubMed Central PMCID: PMCPMC7245777. eng.
   PubMed Web of Science ®Google Scholar
• Ding H, Cui L, Wang C. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma. Neurol Res. 2020 Oct 18:1–10. DOI:https://doi.org/10.1080/01616412.2020.1836465. PubMed PMID: 33070767; eng.
   Google Scholar
• Liu K, Yao H, Wen Y, et al. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy. Biochimica Et Biophysica Acta Mol Basis Dis. 2018 Sep;1864(9Pt B):2871–2880. PubMed PMID: 29807108; eng.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001 Dec;25(4):402–408. PubMed PMID: 11846609.
   PubMed Web of Science ®Google Scholar
• Tohyama O, Matsui J, Kodama K, et al. Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models. J Thyroid Res. 2014;2014:638747. PubMed PMID: 25295214; PubMed Central PMCID: PMCPMC4177084. eng.
   PubMedGoogle Scholar
• Dutton JW 3rd, Artwohl JE, Huang X, et al. Assessment of pain associated with the injection of sodium pentobarbital in laboratory mice (Mus musculus). J Am Assoc Lab Anim Sci. 2019 May 1;58(3):373–379. PubMed PMID: 30857577; PubMed Central PMCID: PMCPMC6526499. eng.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang S, Chen X, et al. CircNT5E acts as a sponge of miR-422a to promote glioblastoma tumorigenesis. Cancer Res. 2018 Sep 1;78(17):4812–4825. PubMed PMID: 29967262; eng.
   PubMed Web of Science ®Google Scholar
• Wang K, Long B, Liu F, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur Heart J. 2016 Sep 1;37(33):2602–2611. PubMed PMID: 26802132; eng.
   PubMed Web of Science ®Google Scholar
• Alegria-Schaffer A, Lodge A, and Vattem K Performing and optimizing Western blots with an emphasis on chemiluminescent detection . Methods Enzymol. 2009 Nov 7; 463 573–599 PubMed PMID: 19892193; eng .
   PubMed Web of Science ®Google Scholar
• Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017 Nov;20(4):409–426. PubMed PMID: 28660302; eng.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Harris AL, Dalgleish AG, et al. Angiogenesis as a biomarker and target in cancer chemoprevention. Lancet Oncol. 2001 Dec;2(12):726–732. PubMed PMID: 11902514; eng.
   PubMed Web of Science ®Google Scholar
• Rajabi S, Dehghan MH, Dastmalchi R, et al. The roles and role-players in thyroid cancer angiogenesis. Endocr J. 2019 Apr 25;66(4):277–293. PubMed PMID: 30842365; eng.
   PubMed Web of Science ®Google Scholar
• Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019 Mar 7;176(6):1248–1264. PubMed PMID: 30849371; PubMed Central PMCID: PMCPMC6410740. eng.
   PubMed Web of Science ®Google Scholar
• Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69(Suppl 3):4–10. PubMed PMID: 16301830; eng.
   PubMed Web of Science ®Google Scholar
• Peng H, Wang L, Su Q, et al. MiR-31-5p promotes the cell growth, migration and invasion of colorectal cancer cells by targeting NUMB. Biomed Pharmacothe. 2019 Jan;109:208–216. PubMed PMID: 30396078; eng.
   PubMed Web of Science ®Google Scholar
• Lu Z, He Q, Liang J, et al. miR-31-5p is a potential circulating biomarker and therapeutic target for oral cancer. Mol Ther Nucleic Acids. 2019 Jun 7;16(471–480):471–480. PubMed PMID: 31051332; PubMed Central PMCID: PMCPMC6495075. eng.
   PubMedGoogle Scholar
• Chen Y, Zhao H, Li H, et al. LINC01234/MicroRNA-31-5p/MAGEA3 axis mediates the proliferation and chemoresistance of hepatocellular carcinoma cells. Mol Ther Nucleic Acids. 2020 Mar 6;19:168–178. PubMed PMID: 31838274; PubMed Central PMCID: PMCPMC6926330. eng.
   PubMedGoogle Scholar
• Aizawa S, Fujiwara Y, Contu VR, et al. Lysosomal putative RNA transporter SIDT2 mediates direct uptake of RNA by lysosomes. Autophagy. 2016;12(3):565–578. PubMed PMID: 27046251; PubMed Central PMCID: PMCPMC4836006. eng.
   PubMed Web of Science ®Google Scholar
• Nguyen TA, Bieging-Rolett KT, Putoczki TL, et al. SIDT2 RNA transporter promotes lung and gastrointestinal tumor development. iScience. 2019 Oct 25;20:14–24. PubMed PMID: 31546103; PubMed Central PMCID: PMCPMC6817685. eng.
   PubMed Web of Science ®Google Scholar
• Chang X, Yang MF, Fan W, et al. Bioinformatic analysis suggests that three hub genes may be a vital prognostic biomarker in pancreatic ductal adenocarcinoma. J Comput Biol. 2020 Nov;27(11):1595–1609. PubMed PMID: 32216644; eng.
   PubMed Web of Science ®Google Scholar